MFS
ESPR

MSI Financial Services’s Esperion Therapeutics ESPR Stock Holding History

MSI Financial Services’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1K Sell
50
-100
-67% -$1.19K ﹤0.01% 3648
2016
Q3 		$2K Hold
150
– – ﹤0.01% 3483
2016
Q2 		$1K Sell
150
-16
-10% -$265 ﹤0.01% 3693
2016
Q1 		$3K Hold
166
– – ﹤0.01% 3387
2015
Q4 		$4K Hold
166
– – ﹤0.01% 3169
2015
Q3 		$4K Buy
166
+116
+232% +$7.28K ﹤0.01% 2493
2015
Q2 		$4K Buy
+50
New +$4.89K ﹤0.01% 2526

Other funds holding ESPR

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

MSI Financial Services's ESPR Position: Q4 2016 in Review

MSI Financial Services reduced its Esperion Therapeutics (ESPR) stake by 67% in Q4 2016, selling an estimated $1.19K and leaving 50 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #3648.

MSI Financial Services first reported a position in ESPR in Q2 2015 and has held it in 7 quarters since. The position peaked at $4K in Q4 2015. 99 funds tracked by Wall St. Rank hold ESPR as of Q4 2016.

  • MSI Financial Services held 50 shares of Esperion Therapeutics worth $1K as of Q4 2016.
  • MSI Financial Services sold 100 Esperion Therapeutics shares in Q4 2016, an estimated $1.19K.
  • Esperion Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3648 holding.
  • MSI Financial Services first reported a position in Esperion Therapeutics in Q2 2015 and has held it in 7 quarters since.
  • MSI Financial Services's Esperion Therapeutics position peaked at $4K in Q4 2015.
  • 99 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.